false 0001596783 0001596783 2024-01-25 2024-01-25

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 26, 2024 (January 25, 2024)

 

 

CATALENT, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36587   20-8737688
(State or other jurisdiction
of incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

14 Schoolhouse Road  
Somerset, New Jersey   08873
(Address of principal executive offices)   (Zip Code)

(732) 537-6200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 203.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbols(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value per share   CTLT   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 25, 2024, Catalent, Inc. (the “Company”) held its 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”), at which shareholders approved, among other things, Amendment No. 1 to the Catalent, Inc. 2018 Omnibus Incentive Plan (the “Plan Amendment”). A description of the Plan Amendment is included in the Company’s definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on December 14, 2023 (as supplemented, the “Proxy Statement”), which description is incorporated herein by reference. Such description does not purport to be complete, and is qualified in its entirety by reference to the Plan Amendment, a copy of which is attached hereto as Exhibit 10.1.

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

On January 25, 2024, the Company held its 2023 Annual Meeting. The final voting results for the matters submitted to a vote of shareholders were as follows:

Proposal No. 1 - Election of Directors

The Company’s shareholders elected the persons listed below as directors for a one-year term expiring at the 2024 annual meeting or until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal.

 

     FOR      AGAINST      ABSTAIN      BROKER
NON-VOTES
 

Michael J. Barber

     152,182,935        4,685,425        490,345        5,823,972  

Steven K. Barg

     155,830,571        1,038,688        489,446        5,823,972  

J. Martin Carroll

     146,141,589        10,738,936        478,180        5,823,972  

Rolf Classon

     141,479,801        15,398,832        480,072        5,823,972  

Frank A. D’Amelio

     154,451,256        2,417,574        489,875        5,823,972  

John J. Greisch

     153,696,212        3,182,821        479,672        5,823,972  

Gregory T. Lucier

     151,114,613        5,764,258        479,834        5,823,972  

Alessandro Maselli

     156,236,378        644,543        477,784        5,823,972  

Donald E. Morel, Jr.

     156,462,652        415,984        480,069        5,823,972  

Stephanie Okey

     154,228,919        2,640,338        489,448        5,823,972  

Michelle R. Ryan

     156,437,051        431,220        490,434        5,823,972  

Jack Stahl

     156,235,444        643,619        479,642        5,823,972  

Proposal No. 2 - Ratification of Appointment of Independent Auditor

The Company’s shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent auditor for fiscal 2024.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

161,413,331    1,278,261    491,085    0

 


Proposal No. 3 – Advisory and Non-Binding Vote on Executive Compensation (Say-on-Pay)

The Company’s shareholders approved, in an advisory and non-binding vote, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

152,656,995    4,216,702    485,008    5,823,972

Proposal No. 4 – Approval of Amendment No. 1 to the Catalent, Inc. 2018 Omnibus Incentive Plan

The Company’s shareholders approved the Plan Amendment.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

154,438,910    2,433,582    486,213    5,823,972

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

10.1    Amendment No. 1 to Catalent, Inc. 2018 Omnibus Incentive Plan
104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Catalent, Inc.
  (Registrant)
By:  

/s/ JOSEPH FERRARO

  Joseph A. Ferraro
 

Senior Vice President,

General Counsel, Chief Compliance Officer & Secretary

  Date: January 26, 2024

Exhibit 10.1

AMENDMENT NO. 1

TO THE CATALENT, INC. 2018 OMNIBUS INCENTIVE PLAN

WHEREAS, Catalent, Inc. (the “Company”) maintains the Catalent, Inc. 2018 Omnibus Incentive Plan (the “Plan”) (capitalized terms not defined herein shall have the meaning assigned to such terms in the Plan);

WHEREAS, pursuant to Section 13 of the Plan, the Board may amend the Plan; provided that amendments must be approved by the Company’s stockholders to the extent necessary to comply with any regulatory requirement applicable to the Plan or if any amendment increases the number of securities that may be issued under the Plan;

WHEREAS, the Board has determined, following the recommendation of the Committee and the Committee’s independent compensation consultant, that it is in the best interests of the Company and its stockholders to amend the Plan, subject to stockholder approval, to (i) increase the aggregate number of shares of Common Stock available for Awards under the Plan, (ii) increase the annual limit for director compensation, (iii) eliminate a provision that allows for recycling of shares of Common Stock withheld for taxes when Options and SARs are exercised as well as shares withheld on net-settlement of Options and SARs, (iv) adjust the “fungible ratio” for debiting Plan shares, (v) require a minimum one-year vesting period for Awards, subject to certain limited exceptions, as has been the practice of the Company prior to the Amendment No. 1 Effective Date (as defined below), and (vi) update the clawback language in the Plan;

WHEREAS, the Board has approved the submission of this Amendment No. 1 to the Plan (this “Amendment No. 1”) to the Company’s stockholders for approval and has conditioned the effectiveness of this Amendment No. 1 on such approval (the date of such approval, the “Amendment No. 1 Effective Date”); and

WHEREAS, if the Company’s stockholders fail to approve this Amendment No. 1, the existing Plan shall continue in full force and effect, and this Amendment No. 1 shall be void and of no effect.

NOW, THEREFORE, the Plan is hereby amended, effective as of the Amendment No. 1 Effective Date, as follow:

 

1.

A new Section 2.1(bbb) is added to read in its entirety as follows:

“‘Amendment No. 1 Effective Date’ means the date on which the Company’s stockholders approve Amendment No. 1 to the Plan.”

 

2.

Section 5(b) of the Plan is hereby amended and restated to read in its entirety as follows:

“(b) The Absolute Share Limit.

(i) Subject to Section 12 and Section 5(d) of the Plan, no more than TOTAL shares of Common Stock shall be available for Awards under the Plan as of the Amendment No. 1 Effective Date (which share limit is comprised of (A) NEW shares of Common Stock authorized for issuance under the Plan as of the Amendment No. 1 Effective Date plus (B) REMAIN shares of Common stock that remained available for future grants under the Plan as of June 30, 2023 minus (C) INTERIM GRANTS representing shares subject to Awards granted under the Plan after June 30, 2023 and prior to the Amendment No. 1 Effective Date) (the aggregate share limit available for Awards under the Plan at any time, including after any reduction in or addition to such aggregate share limit in accordance with this Section 5 or Section 12 of the Plan, the “Absolute Share Limit”), where

(w) ‘TOTAL’ is equal to the lesser of (1) 15,507,520 and (2) NEW plus REMAIN minus INTERIM GRANTS,


(x) ‘NEW’ is equal to 7,625,000,

(y) ‘REMAIN’ is equal to 7,882,520, and

(z) ‘INTERIM GRANTS’ is equal to (1) one share for each share of Common Stock subject to an Option or SAR granted under the Plan after June 30, 2023 and prior to the Amendment No. 1 Effective Date plus (2) 1.7 shares for each share of Common Stock subject to an Award (other than an Option or SAR) granted under the Plan after June 30, 2023 and prior to the Amendment No. 1 Effective Date.

(ii) The Absolute Share Limit shall be reduced after the Amendment No. 1 Effective Date by (A) one share for each share of Common Stock subject to an Option or SAR granted under the Plan and (B) 1.7 shares for each share of Common Stock subject to an Award (other than an Option or SAR) granted under the Plan.”

 

3.

Section 5(c) of the Plan is hereby amended and restated to read in its entirety as follows:

“(c) Awards granted under the Plan shall be subject to the following limitations: (i) subject to Section 12 of the Plan, grants of Options or SARs under the Plan in respect of no more than 1,500,000 shares of Common Stock may be made to any individual Participant during any single fiscal year of the Company (for this purpose, if a SAR is granted in tandem with an Option (such that the SAR expires with respect to the number of shares of Common Stock for which the Option is exercised), only the shares underlying the Option shall count against this limitation); (ii) subject to Section 12 of the Plan, no more than the number of shares of Common Stock equal to the Absolute Share Limit may be issued in the aggregate pursuant to the exercise of Incentive Stock Options granted under the Plan; (iii) subject to Section 12 of the Plan, during any single fiscal year of the Company, no individual Participant may be granted Performance Compensation Awards that are denominated in shares of Common Stock pursuant to Section 11 of the Plan under which more than 750,000 shares of Common Stock may be earned in the aggregate; (iv) the maximum number of shares of Common Stock subject to Awards granted during a single fiscal year to any Non-Employee Director, taken together with any cash fees paid to such Non-Employee Director for services rendered for such fiscal year, shall not exceed $650,000 in total value (calculating the value of any such Award based on the grant date fair value of such Awards for financial reporting purposes and counting compensation towards this limit for the year in which it is earned, and not a later year, in the event payment of the compensation is deferred); and (v) subject to Section 12 of the Plan, during any single fiscal year of the Company, no individual Participant may be granted Performance Compensation Awards that are denominated in cash under which more than $10,000,000 may be earned in the aggregate.”

 

4.

Section 5(d) of the Plan is hereby amended and restated to read in its entirety as follows:

“Other than with respect to Substitute Awards, to the extent that (i) an Award under the Plan expires or is canceled, forfeited, terminated, settled in cash, or otherwise is settled without a delivery to the Participant of the full number of shares of Common Stock to which the Award related, or (ii) after June 30, 2018, an award granted under the 2014 Plan expires or is canceled, forfeited, terminated, settled in cash, or otherwise is settled without a delivery to the Participant of the full number of shares of Common Stock to which the award related, then, in each case, the undelivered shares shall thereupon be added to the shares of Common Stock available for Awards under the Plan in accordance with Section 5(e) of the Plan. Shares of Common Stock withheld by the Company or tendered by the Participant in payment of the Exercise Price or taxes and other amounts relating to an Award (or, after June 30, 2018, shares of Common Stock withheld or tendered to pay the exercise price or taxes or other amounts relating to an award under the 2014 Plan) shall be deemed to constitute shares of Common Stock not issued to the Participant and shall in each case thereupon be added to the shares available for Awards under the Plan in accordance with Section 5(e) of the Plan; provided, however, that such shares shall not become available for issuance hereunder if either (i) the applicable shares are withheld or


surrendered following the termination of the Plan or (ii) at the time the applicable shares are withheld or surrendered, it would constitute a material revision of the Plan subject to stockholder approval under any then-applicable rule of the national securities exchange on which the Common Stock is listed. Upon the exercise of any SAR under the Plan or any stock appreciation right under the 2014 Plan, the Absolute Share Limit shall be reduced only by the net number of shares issued upon such exercise and not by the gross number of shares as to which such right is exercised. Notwithstanding anything to the contrary in the foregoing, after June 30, 2023, the following shares of Common Stock may not again be made available for issuance as Awards under the Plan: (i) shares of Common Stock not issued or delivered as a result of the net settlement of an outstanding Option or SAR, (ii) shares of Common Stock used to pay the Exercise Price or withholding taxes related to any outstanding Option or SAR, or (iii) shares of Common Stock reacquired by the Company as part of the amount received upon exercise of an Option.”

 

5.

Section 5(e) of the Plan is hereby amended and restated to read in its entirety as follows:

“(e) Any share of Common Stock that again becomes available for Awards under the Plan pursuant to this Section 5 shall be added as (i) one share for each share subject to an Option or SAR granted under the Plan or options or stock appreciation rights granted under the 2014 Plan, and (ii) for each share that again becomes available with respect to an Award granted (A) on or prior to June 30, 2023, 2.25 shares, and (B) after June 30, 2023, 1.7 shares, in each case, for each share subject to an Award (other than an Option or SAR) granted under the Plan or an award (other than an option or stock appreciation right) granted under the 2014 Plan.”

 

6.

A new subsection (h) is hereby added to the end of Section 5 of the Plan to read in its entirety as follows:

“(h) Notwithstanding anything to the contrary in any other provision of this Plan, equity-based Awards granted under the Plan on or after the Amendment No. 1 Effective Date shall be subject to a minimum vesting period of not less than one year from the date of grant of the award; provided, however, that the following Awards shall not be subject to the foregoing minimum vesting requirement: (i) Substitute Awards, (ii) shares delivered in lieu of fully vested cash Awards, (iii) any Award to a non-employee director that vests on the earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders that is at least 50 weeks after the immediately preceding year’s annual meeting; and (iv) Awards granted by the Committee that do not, in the aggregate, exceed 5% of the Absolute Share Limit; provided, further, that the restrictions in this Section 5(h) do not apply to the Committee’s discretion to provide for accelerated exercisability or vesting of any Award, including in cases of retirement, Termination, death, Disability or a Change in Control, as set forth in the terms of the Award or otherwise.”

 

7.

The last sentence of Section 14(u) of the Plan is hereby amended and restated to read in its entirety as follows:

“Notwithstanding anything to the contrary in any other provision of this Plan or any agreement setting forth terms of and/or conditions to an Award, each Award granted under the Plan (and/or any amount received with respect to any such Award) shall be subject to reduction, cancellation, forfeiture or recoupment to the extent necessary to comply with any applicable law, stock exchange listing requirement, and/or clawback or recoupment policy of the Company.”

 

8.

Except as expressly set forth in this Amendment No. 1, all other terms and conditions of the Plan shall remain in full force and effect.


IN WITNESS WHEREOF, the Company has caused this Amendment No. 1 to the Plan to be executed by its duly authorized officer to be effective as of the Amendment No. 1 Effective Date.

 

CATALENT, INC.
By:   /s/ JOSEPH FERRARO
  Name: Joseph A. Ferraro
 

Title:  SVP, General Counsel, Chief Compliance Officer and Secretary

v3.23.4
Document and Entity Information
Jan. 25, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001596783
Document Type 8-K
Document Period End Date Jan. 25, 2024
Entity Registrant Name CATALENT, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-36587
Entity Tax Identification Number 20-8737688
Entity Address, Address Line One 14 Schoolhouse Road
Entity Address, City or Town Somerset
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08873
City Area Code (732)
Local Phone Number 537-6200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.01 par value per share
Trading Symbol CTLT
Security Exchange Name NYSE
Entity Emerging Growth Company false

Catalent (NYSE:CTLT)
過去 株価チャート
から 11 2024 まで 12 2024 Catalentのチャートをもっと見るにはこちらをクリック
Catalent (NYSE:CTLT)
過去 株価チャート
から 12 2023 まで 12 2024 Catalentのチャートをもっと見るにはこちらをクリック